Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed

Clinical Trial ID NCT00047333

PubWeight™ 2.35‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00047333

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. Oncotarget 2012 1.55
2 Targeted therapies in the treatment of advanced hepatocellular carcinoma. Clin Med Insights Oncol 2013 0.83
Next 100